The National Health Insurance Civilian Surveillance Alliance yesterday questioned the legitimacy of a certification for pharmaceutical manufacturers after a majority of the manufacturers that were required by the Food and Drug Administration (FDA) to re-file bioequivalence testing (BE) reports for changes made to their products were awarded PIC/S GMP or GMP certification.
BE testing is conducted to ensure that a generic drug delivers the same therapeutic effect as a reference brand-name pharmaceutical.
In response, the agency said that the changes to the drugs were “legitimate” and have no negative impact on drug safety.
Photo: Wei Yi-chia, Taipei Times
At the end of August, the health insurance watchdog held a press conference to report that as many as 3,841 drug products failed to comply with pharmaceutical regulations after making changes to package inserts, packaging and the excipients used in drugs without seeking re-approval by the regulator.
In response, the agency promised to hold risk assessment meetings to evaluate the drugs that had been altered.
This month, the agency announced that 33 out of 3,841 generic drug products would need to be tested for their bioequivalence with brand-name medicines, with 21 more to be examined.
The group found that 10 of the 11 drug manufacturers that produce the 33 drugs are PIC/S GMP (Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme, or the guide to Good Manufacturing Practice for medicinal products) or GMP certified.
“The government has required all pharmaceutical manufacturers to be PIC/S-certified by the end of next year, after which those without will not be permitted to make or sell drugs in Taiwan,” alliance spokeswoman Eva Teng (滕西華) said.
“However, the 10 manufacturers account for 15.8 percent of the 57 PIC/S GMP-certified manufacturers in the country. This makes us concerned that the certification does not guarantee drug quality,” Teng added.
The lack of BE testing reports for drugs that have been altered is a major problem, the group said.
“Changing the excipient, the diluent or the vehicle of a drug could decrease its therapeutic effect,” alliance convener Huang Sue-ying (黃淑英) said, adding that the agency should have ordered that the 33 drug products be pulled off shelves immediately after the announcement this month.
“The agency asked doctors to look for substitutes as soon as possible, and said that the drugs were without health risks,” she said.
FDA official Chi Jo-feng (祁若鳳) said that the PIC/S GMP certificate would not be revoked unless the violations are “grave,” such as producing counterfeit drugs, adding that the drugs were not withdrawn from the market immediately because some patients need time to switch to a new drug.
The agency updated the list in a statement yesterday, announcing the final result of the assessment for the need of BE testing on a total of 54 drugs (including the 33 announced earlier), which said that only nine of the 54 would need to redo BE testing.
One of the 33 drugs required to be tested this month was made exempt because the manufacturer had subsequently handed in relevant documents, while several others decided to revert to the original formula or simply give up the permit for the drug and had their products pulled off shelves, an FDA official said.
US climber Alex Honnold is to attempt to scale Taipei 101 without a rope and harness in a live Netflix special on Jan. 24, the streaming platform announced on Wednesday. Accounting for the time difference, the two-hour broadcast of Honnold’s climb, called Skyscraper Live, is to air on Jan. 23 in the US, Netflix said in a statement. Honnold, 40, was the first person ever to free solo climb the 900m El Capitan rock formation in Yosemite National Park — a feat that was recorded and later made into the 2018 documentary film Free Solo. Netflix previewed Skyscraper Live in October, after videos
Starting on Jan. 1, YouBike riders must have insurance to use the service, and a six-month trial of NT$5 coupons under certain conditions would be implemented to balance bike shortages, a joint statement from transportation departments across Taipei, New Taipei City and Taoyuan announced yesterday. The rental bike system operator said that coupons would be offered to riders to rent bikes from full stations, for riders who take out an electric-assisted bike from a full station, and for riders who return a bike to an empty station. All riders with YouBike accounts are automatically eligible for the program, and each membership account
NUMBERS IMBALANCE: More than 4 million Taiwanese have visited China this year, while only about half a million Chinese have visited here Beijing has yet to respond to Taiwan’s requests for negotiation over matters related to the recovery of cross-strait tourism, the Tourism Administration said yesterday. Taiwan’s tourism authority issued the statement after Chinese-language daily the China Times reported yesterday that the government’s policy of banning group tours to China does not stop Taiwanese from visiting the country. As of October, more than 4.2 million had traveled to China this year, exceeding last year. Beijing estimated the number of Taiwanese tourists in China could reach 4.5 million this year. By contrast, only 500,000 Chinese tourists are expected in Taiwan, the report said. The report
Temperatures are forecast to drop steadily as a continental cold air mass moves across Taiwan, with some areas also likely to see heavy rainfall, the Central Weather Administration (CWA) said. From today through early tomorrow, a cold air mass would keep temperatures low across central and northern Taiwan, and the eastern half of Taiwan proper, with isolated brief showers forecast along Keelung’s north coast, Taipei and New Taipei City’s mountainous areas and eastern Taiwan, it said. Lows of 11°C to 15°C are forecast in central and northern Taiwan, Yilan County, and the outlying Kinmen and Lienchiang (Matsu) counties, and 14°C to 17°C
RSS